ArticleScientific reports2025
Lip and oral cavity cancer in Iran from 1990 to 2019 based on the global burden of disease study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Investigating demographic factors and geographical information mapping (GIS) of oral cancer in Golestan Province, Iran in 2014 to 2021.BMC oral health · 2026Article
- Current and future burden trends of lip and oral cavity cancer based on estimated annual percentage change and the Bayesian age-period-cohort model: a study based on the global burden of disease 2021.Frontiers in oncology · 2025Article
- Burden of lip and oral cavity cancer among young people across South, East, and Southeast Asia: trends from 1990 to 2021 and predictions to 2030.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global burden of disease (GBD) provides valid and reliable assessments of the burden of various diseases. The present study aimed to evaluate the trends of incidence, mortality, and morbidity of lips and oral cavity cancers (LOCC) in Iran from 1990 to 2019 according to GBD 2019 data. Indicators including prevalence, incidence, death, years of life lost (YLL), years lived with disability (YLD), disability adjusted life years (DALY), and mortality-to-incidence ratio (MIR) for two genders and three age groups including 15-49 years, 50-69 years, and 70 + years in Iran were extracted from GBD 2019/calculated. The annual percentage changes of different indicators were analyzed. A joinpoint regression analysis was used to examine the pattern of changes. LOCC incidence in Iran has increased during the studied period, in both genders and all age groups. The average annual percent change (AAPC) of incidence increase was much higher in women (1.36) than in men (0.007), while the highest growth was observed in middle-aged women from 2010 to 2015 (6.9). The general trend (AAPC (Confidence interval (CI)) of YLL in total patients (-0.20 (-0.23, -0.17)), and DALY in total patients (-0.17 (-0.21, -0.14)) had a significant decrease. However, YLL in women (0.48 (0.44, 0.50)) and DALY in women (0.51 (0.48, 0.54)) significantly increased. Moreover, MIR has been declining during the studied period except for the time range of 2002 to 2010, in each of the two sexes (-0.46 in men and - 0.64 in women) and both together (-0.53). A declining trend of YLL/DALY/MIR, and an improvement in screening/diagnosis/treatment/patient care of LOCC in Iran has happened that still needs to be improved. Due to the increase in incidence/mortality/morbidity of LOCC in Iranian women, risk factors exposure and disease screening should be followed seriously.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.